Related references
Note: Only part of the references are listed.Inhibition of human experimental prostate cancers by a targeted cytotoxic luteinizing hormone-releasing hormone analog AN-207
A Stangelberger et al.
PROSTATE (2006)
PAMAM dendrimer-based multifunctional conjugate for cancer therapy: Synthesis, characterization, and functionality
IJ Majoros et al.
BIOMACROMOLECULES (2006)
Specific delivery of corroles to cells via noncovalent conjugates with viral proteins
H Agadjanian et al.
PHARMACEUTICAL RESEARCH (2006)
Molecular heterogeneity analysis of poly(amidoamine) dendrimer-based mono- and multifunctional nanodevices by capillary electrophoresis
XY Shi et al.
ANALYST (2006)
Nuclear proteins: Promising targets for cancer drugs
YL Yao et al.
CURRENT CANCER DRUG TARGETS (2005)
Targeting of cytotoxic luteinizing hormone-releasing hormone analogs to breast, ovarian, endometrial, and prostate cancers
A Nagy et al.
BIOLOGY OF REPRODUCTION (2005)
Physical characterization of blends of poly(D-lactide) and LHRH (a leuprolide decapeptide analog)
C Fraschini et al.
BIOMACROMOLECULES (2005)
Poly(amidoamine) dendrimer-based multifunctional engineered nanodevice for cancer therapy
IJ Majoros et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide
SS Dharap et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Receptors for luteinizing hormone releasing hormone (LHRH) expressed in human non-Hodgkin's lymphomas can be targeted for therapy with the cytotoxic LHRH analogue AN-207
G Keller et al.
EUROPEAN JOURNAL OF CANCER (2005)
Receptors for luteinizing hormone releasing hormone expressed on human renal cell carcinomas can be used for targeted chemotherapy with cytotoxic luteinizing hormone releasing hormone analogues
G Keller et al.
CLINICAL CANCER RESEARCH (2005)
Targeting and inhibition of cell growth by an engineered dendritic nanodevice
TP Thomas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2005)
Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207
JB Engel et al.
FERTILITY AND STERILITY (2005)
EphB2 as a therapeutic antibody drug target for the treatment of colorectal cancer
WG Mao et al.
CANCER RESEARCH (2004)
Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell tines independent of multidrug resistance-1 (MDR-1) system
AR Günthert et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma
MJ Turk et al.
CANCER LETTERS (2004)
In vitro targeting of synthesized anti body-conjugated dendrimer nanoparticles
TP Thomas et al.
BIOMACROMOLECULES (2004)
Synthesis and in vitro testing of J591 antibody-dendrimer conjugates for targeted prostate cancer therapy
AK Patri et al.
BIOCONJUGATE CHEMISTRY (2004)
Combinatorial discovery of tumor targeting peptides using phage display
LA Landon et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors
C Leuschner et al.
PROSTATE (2003)
Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides
SS Dharap et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Acetylation of poly(amidoamine) dendrimers
IJ Majoros et al.
MACROMOLECULES (2003)
Targeted proapoptotic LHRH-BH3 peptide
SS Dharap et al.
PHARMACEUTICAL RESEARCH (2003)
Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor
A Quintana et al.
PHARMACEUTICAL RESEARCH (2002)
Lectin-mediated drug delivery: influence of mucin on cytoadhesion of plant lectins in vitro
M Wirth et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207
A Plonowski et al.
CANCER LETTERS (2002)
Therapeutic cancer targeting peptides
OH Aina et al.
BIOPOLYMERS (2002)
Mannose functionalization of a sixth generation dendrimer
EK Woller et al.
BIOMACROMOLECULES (2001)
Polysaccharides in colon-specific drug delivery
VR Sinha et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2001)
Poly(amidoamine) (PAMAM) dendrimers: from biomimicry to drug delivery and biomedical applications
R Esfand et al.
DRUG DISCOVERY TODAY (2001)
Cytotoxic luteinizing hormone-releasing hormone conjugates and their use in gynecological cancer therapy
C Gründker
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2000)
Share Paper
